Until the efficacy of autologous stem cell therapy in knee OA is proven through randomised trials it is unethical and unprofessional to market treatment directly to patients, the ARA has said in its submission to a TGA review. The association has called for the TGA to adopt the most stringent regulatory option proposed, which would ...
Crack down on unproven stem cell therapy says ARA
By Nicola Garrett
30 Apr 2015